A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy
Gordon, MS, McCaskill-Stevens, WJ, Battiato, LA, Loewy, J, Loesch, D, Breeden, E, Hoffman, R, Beach, KJ, Kuca, B, Kaye, J, Sledge, GW JrVolume:
87
Journal:
Blood
DOI:
10.1182/blood.v87.9.3615.bloodjournal8793615
Date:
May, 1996
File:
PDF, 2.11 MB
1996